207 related articles for article (PubMed ID: 37236965)
1. Altered parabrachial nucleus nociceptive processing may underlie central pain in Parkinson's disease.
Pautrat A; Al Tannir R; Pernet-Gallay K; Soutrenon R; Vendramini E; Sinniger V; Overton PG; David O; Coizet V
NPJ Parkinsons Dis; 2023 May; 9(1):78. PubMed ID: 37236965
[TBL] [Abstract][Full Text] [Related]
2. Enhanced visual responses in the superior colliculus and subthalamic nucleus in an animal model of Parkinson's disease.
Rolland M; Carcenac C; Overton PG; Savasta M; Coizet V
Neuroscience; 2013 Nov; 252():277-88. PubMed ID: 23916713
[TBL] [Abstract][Full Text] [Related]
3. Neuronal inhibition and synaptic plasticity of basal ganglia neurons in Parkinson's disease.
Milosevic L; Kalia SK; Hodaie M; Lozano AM; Fasano A; Popovic MR; Hutchison WD
Brain; 2018 Jan; 141(1):177-190. PubMed ID: 29236966
[TBL] [Abstract][Full Text] [Related]
4. Nigral stimulation for resistant axial motor impairment in Parkinson's disease? A randomized controlled trial.
Weiss D; Walach M; Meisner C; Fritz M; Scholten M; Breit S; Plewnia C; Bender B; Gharabaghi A; Wächter T; Krüger R
Brain; 2013 Jul; 136(Pt 7):2098-108. PubMed ID: 23757762
[TBL] [Abstract][Full Text] [Related]
5. GABA and GABAA receptor changes in the substantia nigra of the rat following quinolinic acid lesions in the striatum closely resemble Huntington's disease.
Nicholson LF; Faull RL; Waldvogel HJ; Dragunow M
Neuroscience; 1995 Jun; 66(3):507-21. PubMed ID: 7644016
[TBL] [Abstract][Full Text] [Related]
6. Subthalamic nucleus lesions reduce low frequency oscillatory firing of substantia nigra pars reticulata neurons in a rat model of Parkinson's disease.
Tseng KY; Kasanetz F; Kargieman L; Pazo JH; Murer MG; Riquelme LA
Brain Res; 2001 Jun; 904(1):93-103. PubMed ID: 11516415
[TBL] [Abstract][Full Text] [Related]
7. The regional, cellular and subcellular localization of GABAA/benzodiazepine receptors in the substantia nigra of the rat.
Nicholson LF; Faull RL; Waldvogel HJ; Dragunow M
Neuroscience; 1992 Sep; 50(2):355-70. PubMed ID: 1331862
[TBL] [Abstract][Full Text] [Related]
8. Distinct progression pattern of susceptibility MRI in the substantia nigra of Parkinson's patients.
Du G; Lewis MM; Sica C; He L; Connor JR; Kong L; Mailman RB; Huang X
Mov Disord; 2018 Sep; 33(9):1423-1431. PubMed ID: 29756399
[TBL] [Abstract][Full Text] [Related]
9. Functional changes of the basal ganglia circuitry in Parkinson's disease.
Blandini F; Nappi G; Tassorelli C; Martignoni E
Prog Neurobiol; 2000 Sep; 62(1):63-88. PubMed ID: 10821982
[TBL] [Abstract][Full Text] [Related]
10. Pathological changes in dendrites of substantia nigra neurons in Parkinson's disease: a Golgi study.
Patt S; Gertz HJ; Gerhard L; Cervós-Navarro J
Histol Histopathol; 1991 Jul; 6(3):373-80. PubMed ID: 1725760
[TBL] [Abstract][Full Text] [Related]
11. Changed firing activity of nigra dopaminergic neurons in Parkinson's disease.
Chen XY; Liu C; Xue Y; Chen L
Neurochem Int; 2023 Jan; 162():105465. PubMed ID: 36563966
[TBL] [Abstract][Full Text] [Related]
12. Revealing a novel nociceptive network that links the subthalamic nucleus to pain processing.
Pautrat A; Rolland M; Barthelemy M; Baunez C; Sinniger V; Piallat B; Savasta M; Overton PG; David O; Coizet V
Elife; 2018 Aug; 7():. PubMed ID: 30149836
[TBL] [Abstract][Full Text] [Related]
13. GABAA receptor-mediated inhibition of rat substantia nigra dopaminergic neurons by pars reticulata projection neurons.
Tepper JM; Martin LP; Anderson DR
J Neurosci; 1995 Apr; 15(4):3092-103. PubMed ID: 7722648
[TBL] [Abstract][Full Text] [Related]
14. Levodopa enhances synaptic plasticity in the substantia nigra pars reticulata of Parkinson's disease patients.
Prescott IA; Dostrovsky JO; Moro E; Hodaie M; Lozano AM; Hutchison WD
Brain; 2009 Feb; 132(Pt 2):309-18. PubMed ID: 19050033
[TBL] [Abstract][Full Text] [Related]
15. The parabrachial nucleus is a critical link in the transmission of short latency nociceptive information to midbrain dopaminergic neurons.
Coizet V; Dommett EJ; Klop EM; Redgrave P; Overton PG
Neuroscience; 2010 Jun; 168(1):263-72. PubMed ID: 20363297
[TBL] [Abstract][Full Text] [Related]
16. Subthalamic stimulation-induced synaptic responses in substantia nigra pars compacta dopaminergic neurons in vitro.
Iribe Y; Moore K; Pang KC; Tepper JM
J Neurophysiol; 1999 Aug; 82(2):925-33. PubMed ID: 10444687
[TBL] [Abstract][Full Text] [Related]
17. Unilateral lesion of the pedunculopontine nucleus induces hyperactivity in the subthalamic nucleus and substantia nigra in the rat.
Breit S; Lessmann L; Benazzouz A; Schulz JB
Eur J Neurosci; 2005 Nov; 22(9):2283-94. PubMed ID: 16262666
[TBL] [Abstract][Full Text] [Related]
18. 5,7-dihydroxytryptamine lesion of the dorsal raphe nucleus alters neuronal activity of the subthalamic nucleus in normal and 6-hydroxydopamine-lesioned rats.
Liu J; Chu YX; Zhang QJ; Wang S; Feng J; Li Q
Brain Res; 2007 May; 1149():216-22. PubMed ID: 17376410
[TBL] [Abstract][Full Text] [Related]
19. Lesion of the pedunculopontine nucleus reverses hyperactivity of the subthalamic nucleus and substantia nigra pars reticulata in a 6-hydroxydopamine rat model.
Breit S; Lessmann L; Unterbrink D; Popa RC; Gasser T; Schulz JB
Eur J Neurosci; 2006 Oct; 24(8):2275-82. PubMed ID: 17042796
[TBL] [Abstract][Full Text] [Related]
20. Synaptic localization of ionotropic glutamate receptors in the rat substantia nigra.
Chatha BT; Bernard V; Streit P; Bolam JP
Neuroscience; 2000; 101(4):1037-51. PubMed ID: 11113353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
